The CAPTAIN trial shows faster recovery, fewer complications, and better early function with the minimally invasive therapy ...

Getting a timely scan within 48 hours for accident and emergency patients with blood in urine (hematuria) speeds up bladder ...

Let's see what is getting investors excited today. The post Why is this ASX 300 stock rocketing 17% today? appeared first on The Motley Fool Australia.

The study "Reducing MRI Use in Organised Prostate Cancer Testing Using Blood-Based Biomarkers - the OPT Stockholm3 Study" ...

A North Carolina man’s life‑changing prostate cancer diagnosis is opening doors to conversations on men’s health.

Discover six prostate cancer companies advancing the next generation of therapies for all stages of the disease.

Read more about the factors that patients with prostate cancer value most in treatment decisions, as reported at EAU 2026.

Healthcare provider, LivingCare Group has been selected as the proposed imaging partner for the IMProVE clinical trial, a ...

AI-assisted imaging improved prostate cancer diagnosis and biopsy decision-making in new research presented at EAU 2026.

(UroToday.com) The 2026 European Association of Urology (EAU) annual meeting featured a PARP inhibitors for prostate cancer session and a presentation by Dr. Himisha Beltran discussing how to read a ...

Early-stage prostate cancer rarely causes symptoms, making routine screening the most reliable way to catch it before it ...

Prostate cancer is the leading cancer among Kenyan men, with an estimated 3,582 men being diagnosed with the disease at some ...